Drug Merger ManiaBy
Feel the tremors? That's the $200 billion drug industry, in seismic upheaval. Consolidation is reshaping the landscape, as giant multinational producers search for new products and wider distribution. Within a few years, the way pharmaceuticals are invented, made, and sold will bear little resemblance to the methods of a decade ago.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.